Eduardo Castanon

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Prognostic value of existing scoring systems for early mortality in phase I immunotherapy trials: a head-to-head real-world cohort study.

Prognostic value of existing scoring systems for early mortality in phase I immunotherapy trials: a head-to-head real-world cohort study.

Journal: Frontiers in oncology

Published: April 07, 2026

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 27, 2026

First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.

First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.

Journal: Neuro-oncology advances

Published: August 22, 2025

Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study.

Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study.

Journal: Clinical colorectal cancer

Published: March 31, 2025

Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.

Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.

Journal: Cancer

Published: March 04, 2025

Clinical practice guide for nurses that optimizes nurse's comprehensive care of patients undergoing immunotherapy.

Clinical practice guide for nurses that optimizes nurse's comprehensive care of patients undergoing immunotherapy.

Journal: Enfermeria clinica

Published: July 15, 2024

Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials.

Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials.

Journal: BJS open

Published: December 11, 2023

Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study.

Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study.

Journal: Cancer

Published: December 07, 2023

Novel strategies exploiting interleukin-12 in cancer immunotherapy.

Novel strategies exploiting interleukin-12 in cancer immunotherapy.

Journal: Pharmacology & therapeutics

Published: January 05, 2022

Bayesian interpretation of immunotherapy trials with dynamic treatment effects.

Bayesian interpretation of immunotherapy trials with dynamic treatment effects.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 16, 2021

Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.

Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.

Journal: Cancers

Published: June 07, 2021

Intratumoural administration and tumour tissue targeting of cancer immunotherapies.

Intratumoural administration and tumour tissue targeting of cancer immunotherapies.

Journal: Nature reviews. Clinical oncology

Published: March 24, 2021

Showing 1-12 of 59

Last Updated: 09/26/2026